Evidence map›Paper›PMID 38156294›Full record

ReviewMedComm2023

The role of mitochondrial dynamics in disease.

Yujuan Wang, Xinyan Dai, Hui Li, Huiling Jiang, Junfu Zhou, Shiying Zhang, Jiacheng Guo, Lidu Shen, Huantao Yang, Jie Lin and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in MedComm, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Yujuan WangImmunotherapy Laboratory Qinghai Tibet Plateau Research Institute Southwest Minzu University Chengdu Sichuan China.
Xinyan DaiImmunotherapy Laboratory Qinghai Tibet Plateau Research Institute Southwest Minzu University Chengdu Sichuan China.ORCID https://orcid.org/0000-0002-5060-2857
Hui LiImmunotherapy Laboratory College of Pharmacology Southwest Minzu University Chengdu Sichuan China.
Huiling JiangImmunotherapy Laboratory College of Pharmacology Southwest Minzu University Chengdu Sichuan China.
Junfu ZhouImmunotherapy Laboratory College of Pharmacology Southwest Minzu University Chengdu Sichuan China.
Shiying ZhangImmunotherapy Laboratory Qinghai Tibet Plateau Research Institute Southwest Minzu University Chengdu Sichuan China.
Jiacheng GuoImmunotherapy Laboratory Qinghai Tibet Plateau Research Institute Southwest Minzu University Chengdu Sichuan China.
Lidu ShenImmunotherapy Laboratory College of Pharmacology Southwest Minzu University Chengdu Sichuan China.
Huantao YangImmunotherapy Laboratory Qinghai Tibet Plateau Research Institute Southwest Minzu University Chengdu Sichuan China.
Jie LinImmunotherapy Laboratory College of Pharmacology Southwest Minzu University Chengdu Sichuan China.
Hengxiu YanImmunotherapy Laboratory College of Pharmacology Southwest Minzu University Chengdu Sichuan China.
Southwest Minzu University · CNHanalei Watershed Hui · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria are multifaceted and dynamic organelles regulating various important cellular processes from signal transduction to determining cell fate. As dynamic properties of mitochondria, fusion and fission accompanied with mitophagy, undergo constant changes in number and morphology to sustain mitochondrial homeostasis in response to cell context changes. Thus, the dysregulation of mitochondrial dynamics and mitophagy is unsurprisingly related with various diseases, but the unclear underlying mechanism hinders their clinical application. In this review, we summarize the recent developments in the molecular mechanism of mitochondrial dynamics and mitophagy, particularly the different roles of key components in mitochondrial dynamics in different context. We also summarize the roles of mitochondrial dynamics and target treatment in diseases related to the cardiovascular system, nervous system, respiratory system, and tumor cell metabolism demanding high-energy. In these diseases, it is common that excessive mitochondrial fission is dominant and accompanied by impaired fusion and mitophagy. But there have been many conflicting findings about them recently, which are specifically highlighted in this view. We look forward that these findings will help broaden our understanding of the roles of the mitochondrial dynamics in diseases and will be beneficial to the discovery of novel selective therapeutic targets.

Indexed as

contextdiseasemitochondrial dynamicsmitophagytarget treatment

Identifiers

PMID38156294
PMCPMC10753647
OpenAlexW4390351058

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.